Please use this identifier to cite or link to this item: http://hdl.handle.net/10316/2811
Title: Relative bioavailability and bioquivalence of three different oral formulations of Eslicarbazepine Acetate
Authors: Nunes, Teresa 
Falcão, Amílcar 
Almeida, Luís 
Lima, Ricardo 
Tavares, Susana 
Neta, Carla 
Fontes-Ribeiro, Carlos 
Macedo, Tice 
Soares-da-Silva, Patricio 
Keywords: eslicarbazepine acetate; bioequivalence; bioavailability
Issue Date: 2005
Publisher: Blackwell Publishing, Inc.; International League Against Epilepsy
Citation: NUNES, Teresa; et al. - Relative bioavailability and bioquivalence of three different oral formulations of Eslicarbazepine Acetate. Epilepsia, 46: Suppl. 8 (2005) 200.
Series/Report no.: Abstract nr 2.325
Abstract: To investigate the bioavailability and bioequivalence of three formulations of eslicarbazepine acetate: 50 mg/mL oral suspension (Test 1), 200 mg tablets (Test 2) and 800 mg tablets (Reference)
Description: AES Proceedings of the Annual Meeting of the American Epilepsy Society
URI: http://hdl.handle.net/10316/2811
Rights: openAccess
Appears in Collections:FFUC- Resumos em Livros de Actas

Files in This Item:
File Description SizeFormat
AES Proceedings - Epilepsia, 46(Suppl. 8), 1-3 C.pdf129.06 kBAdobe PDFView/Open
Show full item record

Page view(s) 50

452
checked on Jul 28, 2020

Download(s)

89
checked on Jul 28, 2020

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.